<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A girl with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down's syndrome</z:e>, <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and sagittal sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> is described </plain></SENT>
<SENT sid="1" pm="."><plain>She was diagnosed after <z:hpo ids='HP_0011009'>acute</z:hpo> neurological deterioration by MRI and angiography </plain></SENT>
<SENT sid="2" pm="."><plain>Recombinant tissue plasminogen activator (r-<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) was injected locally to recanalise the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The patient's condition significantly improved and she was discharged </plain></SENT>
<SENT sid="4" pm="."><plain>After 2 years of follow-up the child remains asymptomatic </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya syndrome</z:e> and <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> should not be overlooked as a cause of <z:hpo ids='HP_0011009'>acute</z:hpo> neurological deterioration in a child with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down's syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>MRA appears to be a safe and accurate alternative to traditional angiography for the diagnosis of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Local fibrinolysis with r-<z:chebi fb="6" ids="15702,53394">TPA</z:chebi> is the treatment of choice for <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> due to its safety and efficacy </plain></SENT>
</text></document>